Biltmore Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.55M | Sell |
|
|||||
|
2025
Q2 | $1.4M | Sell |
|
|||||
|
2025
Q1 | $1.41M | Sell |
|
|||||
|
2024
Q4 | $1.64M | Sell |
|
|||||
|
2024
Q3 | $1.89M | Buy |
|
|||||
|
2024
Q2 | $1.68M | Buy |
|
|||||
|
2024
Q1 | $1.65M | Buy |
|
|||||
|
2023
Q4 | $1.34M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Buy |
|
|||||
|
2023
Q2 | $2.33M | Buy |
|
|||||
|
2023
Q1 | $2.08M | Sell |
|
|||||
|
2022
Q4 | $2.61M | Buy |
|
|||||
|
2022
Q3 | $2.16M | Buy |
|
|||||
|
2022
Q2 | $1.53M | Sell |
|
|||||
|
2022
Q1 | $2.5M | Sell |
|
|||||
|
2021
Q4 | $4.51M | Buy |
|
|||||
|
2021
Q3 | $452K | Sell |
|
|||||
|
2021
Q2 | $543K | Sell |
|
|||||
|
2021
Q1 | $553K | Buy |
|
|||||
|
2020
Q4 | $552K | Buy |
|
|||||
|
2020
Q3 | $386K | Sell |
|
|||||
|
2020
Q2 | $430K | Buy |
|
|||||
|
2020
Q1 | $289K | Sell |
|
|||||
|
2019
Q4 | $439K | Sell |
|
|||||
|
2019
Q3 | $4.01M | Sell |
|
|||||
|
2019
Q2 | $4.63M | Buy |
|
|||||
|
2019
Q1 | $4.27M | Buy |
|
|||||
|
2018
Q4 | $3.13M | Buy |
|
|||||
|
2018
Q3 | $2.99M | Sell |
|
|||||
|
2018
Q2 | $2.98M | Buy |
|
|||||
|
2018
Q1 | $1.8M | Buy |
|